Revolutionising cellular therapies for cancer and beyond
We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
‘Off-the-Shelf’ Immunotherapy: Manufacture of Cancer-Killing Cells from Donor Cells
By Christine Filippis / October 8, 2021
‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells Cellular immunotherapy is revolutionizing cancer treatment. However, treatments...
Read More
Cartherics CEO contributes his expertise
By Christine Filippis / October 7, 2021
Alan Trounson joins regenerative medicine advisory committee By Leigh Dayton 7 October 2021 According to Cartherics CEO Alan Trounson, taking...
Read More
Cartherics Board Member hits the Airwaves
By Christine Filippis / September 14, 2021
On Thursday, 2 September, in an interview with Jack Hodgins on 2NUR.FM's 'Wellbeing' segment, Professor Bryan Williams (Cartherics Non-Executive Board...
Read More
